Influence of methodology on outcomes of randomised clozapine trials

Citation
K. Wahlbeck et al., Influence of methodology on outcomes of randomised clozapine trials, PHARMACOPS, 33(2), 2000, pp. 54-59
Citations number
49
Categorie Soggetti
Neurosciences & Behavoir
Journal title
PHARMACOPSYCHIATRY
ISSN journal
01763679 → ACNP
Volume
33
Issue
2
Year of publication
2000
Pages
54 - 59
Database
ISI
SICI code
0176-3679(200003)33:2<54:IOMOOO>2.0.ZU;2-O
Abstract
The aim of this study was to clarify the impact of various methodological q uality factors on reported outcome of randomised clozapine trials. Trials c omparing the atypical antipsychotic clozapine with other antipsychotic drug s were identified in extensive electronic searches. Two independent reviewe rs extracted data on methodology and primary outcomes, and assessed trial q uality by use of three sets of criteria (Cochrane, Delphi, and Jadad). Ther e was no association between trial quality, as measured by any of the crite ria sets, and primary measures of outcome. Trials with the best score for r andomisation and concealment according to the Delphi scale had a significan tly lower relative risk for relapse in clozapine-treated groups, and studie s with well reported random order generation according to Jadad criteria te nded to have better odds ratios for clinical improvement on clozapine. Thes e findings strengthen the evidence of true clozapine superiority in these a spects, No other quality items correlated to the primary outcomes. Inadequa te randomisation techniques may be a source of bias in clozapine studies, b ut much more research is needed on the connections between trial quality an d trial outcome.